The Terasaki Institute for Biomedical Innovation (TIBI) will probably be hosting the Terasaki Innovation Summit on March 8-10, 2023, on the UCLA Meyer & Renee Luskin Center in Los Angeles. This inaugural event will concentrate on improving technological and entrepreneurial translation of personalized medicines – bringing biomedical innovations from the laboratory to the true world.
Featuring thought-leaders and innovators discussing the long run of biomedicine, bringing ideas from bench to bedside, and constructing and financing spin-off corporations, the Terasaki Innovation Summit is crucial for academics interested by commercializing their technologies and industry attendees interested by learning concerning the newest technologies in personalized medicine that academia has to supply.
Too many technologies die on the vine due to the gulf between industry and academia, and the tremendous roadblocks in place making licensing technologies a challenge. The Terasaki Innovation Summit is targeted on helping innovators bridge those gaps to bring latest personalized and precision medicines to market and help have fun the legacy of our founder who so successfully developed essential organ transplantation technologies which can be still utilized by patients to at the present time.”
Ali Khademhosseini, Ph.D., TIBI’s Director and CEO
Focused on translating innovations in personalized medicine
The Inaugural Terasaki Innovation Summit will include leading investigators discussing the newest advances in micro- and nanotechnologies and applications in diagnostics, therapeutic drug delivery and regenerative medicine. As well as, key business leaders and experts in translation, innovation, enterprise investment, IP, and more will probably be available to share their knowledge and business experience.
Thought leaders will share their cutting-edge work and groundbreaking innovations, with keynote speakers including:
- Joseph DeSimone, Stanford Professor whose research focuses on developing latest vaccine platforms for pediatrics
- Peter Diamandis, leading entrepreneur, technological innovation counselor and founding father of XPRIZE
- Robert Langer, MIT Professor, prolific researcher, legendary pioneer of recent biomedical technologies, and founding father of over forty biotechnology corporations
- Samir Mitragotri, Ph.D., renowned researcher within the fields of drug delivery and biological barriers
- Xiling Shen, Ph.D., founder and CEO of Xilis, Inc. and TIBI’s Chief Scientific Officer
Introducing the Paul Terasaki and Hisako Terasaki Young Awards
The Terasaki Innovation Summit may even mark the debut of recent awards for innovators, including the Paul Terasaki Award, which can recognize an attending innovator with a $25,000 grant, and the Hisako Terasaki Young Innovator Travel Award, recognizing young innovators in the sector by reimbursing travel expenses.
Attending the Terasaki Innovation Summit
The Terasaki Innovation Summit, March 8-10, 2023 at UCLA’s Luskin Conference Center in Los Angeles, guarantees to be a one-of-a-kind gathering of a few of the most distinguished names in the sector of biomedical engineering and can provide a wealth of data and opportunities for networking with others within the scientific community. Investors, industry, and academics interested by attending can register at the next link, with discounts available for college kids and academics: https://whova.com/portal/registration/tibi_202303/
Early bird registration ends November 18th, 2022.
Source:
Terasaki Institute for Biomedical Innovation